ALPHA & OMEGA SEMICONDUCTOR (AOSL)

BMG6331P1041 - Common Stock

38.98  +0.67 (+1.75%)

After market: 39.75 +0.77 (+1.98%)

Fundamental Rating

3

AOSL gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 108 industry peers in the Semiconductors & Semiconductor Equipment industry. AOSL scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. AOSL is quite expensive at the moment. It does show a decent growth rate.



2

1. Profitability

1.1 Basic Checks

In the past year AOSL was profitable.
AOSL had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: AOSL reported negative net income in multiple years.
AOSL had a positive operating cash flow in each of the past 5 years.

1.2 Ratios

AOSL's Return On Assets of -1.70% is in line compared to the rest of the industry. AOSL outperforms 40.74% of its industry peers.
AOSL has a Return On Equity (-2.16%) which is in line with its industry peers.
Industry RankSector Rank
ROA -1.7%
ROE -2.16%
ROIC N/A
ROA(3y)11.66%
ROA(5y)8.09%
ROE(3y)17.74%
ROE(5y)13.31%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Gross Margin of AOSL (25.13%) is worse than 73.15% of its industry peers.
In the last couple of years the Gross Margin of AOSL has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for AOSL so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 25.13%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.64%
GM growth 5Y0.44%

4

2. Health

2.1 Basic Checks

AOSL does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, AOSL has more shares outstanding
AOSL has more shares outstanding than it did 5 years ago.
The debt/assets ratio for AOSL has been reduced compared to a year ago.

2.2 Solvency

AOSL has an Altman-Z score of 4.33. This indicates that AOSL is financially healthy and has little risk of bankruptcy at the moment.
AOSL has a Altman-Z score of 4.33. This is comparable to the rest of the industry: AOSL outperforms 55.56% of its industry peers.
AOSL has a Debt/Equity ratio of 0.03. This is a healthy value indicating a solid balance between debt and equity.
AOSL has a Debt to Equity ratio of 0.03. This is in the better half of the industry: AOSL outperforms 61.11% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Altman-Z 4.33
ROIC/WACCN/A
WACC14.56%

2.3 Liquidity

A Current Ratio of 2.65 indicates that AOSL has no problem at all paying its short term obligations.
AOSL's Current ratio of 2.65 is in line compared to the rest of the industry. AOSL outperforms 47.22% of its industry peers.
AOSL has a Quick Ratio of 1.44. This is a normal value and indicates that AOSL is financially healthy and should not expect problems in meeting its short term obligations.
AOSL has a worse Quick ratio (1.44) than 70.37% of its industry peers.
Industry RankSector Rank
Current Ratio 2.65
Quick Ratio 1.44

4

3. Growth

3.1 Past

AOSL shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -48.98%.
The earnings per share for AOSL have been decreasing by -12.80% on average. This is quite bad
AOSL shows a decrease in Revenue. In the last year, the revenue decreased by -0.75%.
Measured over the past years, AOSL shows a small growth in Revenue. The Revenue has been growing by 7.83% on average per year.
EPS 1Y (TTM)-48.98%
EPS 3Y-40.34%
EPS 5Y-12.8%
EPS Q2Q%-36.36%
Revenue 1Y (TTM)-0.75%
Revenue growth 3Y0.02%
Revenue growth 5Y7.83%
Sales Q2Q%0.69%

3.2 Future

AOSL is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 27.50% yearly.
AOSL is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.83% yearly.
EPS Next Y-39.13%
EPS Next 2Y13.28%
EPS Next 3Y27.5%
EPS Next 5YN/A
Revenue Next Year4.18%
Revenue Next 2Y6.18%
Revenue Next 3Y6.83%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.

2

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 77.96 indicates a quite expensive valuation of AOSL.
The rest of the industry has a similar Price/Earnings ratio as AOSL.
The average S&P500 Price/Earnings ratio is at 27.29. AOSL is valued rather expensively when compared to this.
A Price/Forward Earnings ratio of 48.99 indicates a quite expensive valuation of AOSL.
AOSL's Price/Forward Earnings ratio is in line with the industry average.
The average S&P500 Price/Forward Earnings ratio is at 23.78. AOSL is valued rather expensively when compared to this.
Industry RankSector Rank
PE 77.96
Fwd PE 48.99

4.2 Price Multiples

69.44% of the companies in the same industry are more expensive than AOSL, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 23.24

4.3 Compensation for Growth

AOSL's earnings are expected to grow with 27.50% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y13.28%
EPS Next 3Y27.5%

0

5. Dividend

5.1 Amount

No dividends for AOSL!.
Industry RankSector Rank
Dividend Yield N/A

ALPHA & OMEGA SEMICONDUCTOR

NASDAQ:AOSL (12/23/2024, 5:40:32 PM)

After market: 39.75 +0.77 (+1.98%)

38.98

+0.67 (+1.75%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)11-04 2024-11-04/amc
Earnings (Next)02-04 2025-02-04/amc
Inst Owners68.56%
Inst Owner Change-0.97%
Ins Owners16.7%
Ins Owner Change-1.32%
Market Cap1.13B
Analysts75.56
Price Target38.76 (-0.56%)
Short Float %6.67%
Short Ratio2.48
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)48.61%
Min EPS beat(2)-6.42%
Max EPS beat(2)103.64%
EPS beat(4)3
Avg EPS beat(4)56.52%
Min EPS beat(4)-6.42%
Max EPS beat(4)103.64%
EPS beat(8)5
Avg EPS beat(8)111.82%
EPS beat(12)8
Avg EPS beat(12)77.06%
EPS beat(16)12
Avg EPS beat(16)63.46%
Revenue beat(2)0
Avg Revenue beat(2)-1.08%
Min Revenue beat(2)-1.18%
Max Revenue beat(2)-0.97%
Revenue beat(4)0
Avg Revenue beat(4)-1.47%
Min Revenue beat(4)-1.92%
Max Revenue beat(4)-0.97%
Revenue beat(8)1
Avg Revenue beat(8)-1.47%
Revenue beat(12)4
Avg Revenue beat(12)-0.9%
Revenue beat(16)8
Avg Revenue beat(16)0.04%
PT rev (1m)-9.52%
PT rev (3m)-9.52%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-54.72%
EPS NY rev (1m)-23.97%
EPS NY rev (3m)-52.15%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.3%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-3.68%
Valuation
Industry RankSector Rank
PE 77.96
Fwd PE 48.99
P/S 1.72
P/FCF N/A
P/OCF 49.35
P/B 1.26
P/tB 1.27
EV/EBITDA 23.24
EPS(TTM)0.5
EY1.28%
EPS(NY)0.8
Fwd EY2.04%
FCF(TTM)-0.3
FCFYN/A
OCF(TTM)0.79
OCFY2.03%
SpS22.68
BVpS30.84
TBVpS30.75
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.7%
ROE -2.16%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 25.13%
FCFM N/A
ROA(3y)11.66%
ROA(5y)8.09%
ROE(3y)17.74%
ROE(5y)13.31%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.64%
GM growth 5Y0.44%
F-Score5
Asset Turnover0.58
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Debt/EBITDA 0.62
Cap/Depr 56.95%
Cap/Sales 4.78%
Interest Coverage N/A
Cash Conversion 54.69%
Profit Quality N/A
Current Ratio 2.65
Quick Ratio 1.44
Altman-Z 4.33
F-Score5
WACC14.56%
ROIC/WACCN/A
Cap/Depr(3y)215.41%
Cap/Depr(5y)184.51%
Cap/Sales(3y)13.12%
Cap/Sales(5y)12.77%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-48.98%
EPS 3Y-40.34%
EPS 5Y-12.8%
EPS Q2Q%-36.36%
EPS Next Y-39.13%
EPS Next 2Y13.28%
EPS Next 3Y27.5%
EPS Next 5YN/A
Revenue 1Y (TTM)-0.75%
Revenue growth 3Y0.02%
Revenue growth 5Y7.83%
Sales Q2Q%0.69%
Revenue Next Year4.18%
Revenue Next 2Y6.18%
Revenue Next 3Y6.83%
Revenue Next 5YN/A
EBIT growth 1Y-309.2%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year271.77%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-139.52%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-86.9%
OCF growth 3Y-41.54%
OCF growth 5Y-3.92%